Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A

British Journal of Dermatology

Volumn 147, Issue 4, 2002, Pages 743-747

  De Rie, M A ^a   Sommer, A ^b   Hoekzema, R ^a   Neumann, H A M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

High frequency ultrasound; Necrobiosis lipoidica; Photochemotherapy; Psoralen; Topical psoralen plus ultraviolet A; Treatment

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID DERIVATIVE; PSORALEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLISTER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DERMIS; DISEASE SEVERITY; DRUG EFFECT; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTICENTER STUDY; NECROBIOSIS LIPOIDICA; PATIENT SELECTION; PRIORITY JOURNAL; PUVA; RADIATION RESPONSE; SIDE EFFECT; SKIN ATROPHY; SKIN ULCER; THICKNESS; TREATMENT OUTCOME; ULCER HEALING; ULTRASOUND; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LEG DERMATOSES; MALE; MIDDLE AGED; NECROBIOSIS LIPOIDICA; PROSPECTIVE STUDIES; PUVA THERAPY; SKIN; TREATMENT OUTCOME;

EID: 0036404922     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04856.x     Document Type: Article

References (16)

1. Jelinek JE. Cutaneous manifestations of diabetes mellitus. Int J Dermatol 1994; 33: 605-17.
2. Kavanagh GM, Novelli M, Hartog M, Kennedy CT. Necrobiosis lipoidica: Involvement of atypical sites. Clin Exp Dermatol 1993; 18: 543-4.
3. Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol 1996; 27: 50-6.
4. Haralambous S, Blackwell C, Mappouras DG et al. Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with or without insulin-dependent diabetes mellitus. Autoimmunity 1995; 20: 267-75.
5. Ullman S, Dahl MV. Necrobiosis lipoidica. An immunofluorescence study. Arch Dermatol 1977; 113: 1671-3.
6. Kossard S, Collins E, Wargon O, Downie D. Squamous carcinomas developing in bilateral lesions of necrobiosis lipoidica. Australas J Dermatol 1987; 28: 14-17.
7. Taniguchi Y, Sakamoto T, Shimizu M. A case of necrobiosis lipoidica treated with systemic corticosteroid. J Dermatol 1993; 20: 304-7.
8. Arbiser JL, Moschella SL. Clofazimine: A review of its medical uses and mechanisms of action. J Am Acad Dermatol 1995; 32: 241-7.
9. Smith K. Ulcerating necrobiosis lipoidica resolving in response to cyclosporine A. Dermatol Online J 1997; 3: 2.
10. Heymann WR. Necrobiosis lipoidica treated with topical tretinoin. Cutis 1996; 58: 53-4.
11. Statham B, Finlay AY, Marks R. A randomised double-blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica. Acta Derm Venereol (Stockh) 1981; 61: 270-1.
12. Handfield-Jones S, Jones S, Peachey R. High dose nicotinamide in the treatment of necrobiosis lipoidica. Br J Dermatol 1988; 118: 693-6.
13. Pathak MA, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol 1992; 14: 3-22.
14. de Rie MA, van Eendenburg JP, Versnick AC et al. A new psoralen-containing gel for topical PUVA therapy: Development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema. Br J Dermatol 1995; 132: 964-9.
15. Patel GK, Harding KG, Mills CM. Severe disabling Köebnerizing ulcerated necrobiosis lipoidica successfully managed with topical PUVA. Br J Dermatol 2000; 143: 668-9.
16. McKenna DB, Cooper EJ, Tidman MJ. Topical psoralen plus ultraviolet A treatment for necrobiosis lipoidica. Br J Dermatol 2000; 143: 1333-5.